Back to ADAR1 Capital Management, LLC

ADAR1 Capital Management, LLC

All holdings · as of Dec 31, 2025

249 positions

CompanyClassValueShares% of portfolio
DANAHER CORP /DE$5.86M25,6000.4%
Climb Bio, Inc.CLYMCommon Stock$5.73M1,432,4750.4%
UNIQURE NV$5.63M235,1550.4%
RHYTHM PHARMACEUTICALS, INC.$5.50M51,3490.4%
OAKTREE ACQUISITION CORP III$5.49M516,4820.4%
ASCENDIS PHARMA A/S$5.40M25,3140.4%
AGIOS PHARMACEUTICALS, INC.$5.12M188,0000.4%
SPRUCE BIOSCIENCES, INC.SPRBCommon Stock$5.05M58,0000.4%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$4.94M136,2310.4%
Krystal Biotech, Inc.$4.93M20,0140.4%
PALISADE BIO, INC.$4.71M2,004,8450.4%
ARS Pharmaceuticals, Inc.$4.31M369,5690.3%
BIOGEN INC.$4.28M24,3000.3%
NEWAMSTERDAM PHARMA COMPANY$4.16M118,6230.3%
AMERICAN EXCEPTIONALISM ACQU$4.07M357,5390.3%
ARROWHEAD PHARMACEUTICALS, INC.$3.86M58,2000.3%
ATAI BECKLEY NV$3.74M913,2420.3%
Corvus Pharmaceuticals, Inc.$3.59M465,8750.3%
Janux Therapeutics, Inc.$3.39M245,4520.3%
Monte Rosa Therapeutics, Inc.$3.38M215,7520.3%
AVADEL PHARMACEUTICALS PLC$3.24M150,5320.2%
Contineum Therapeutics, Inc.$3.19M278,9610.2%
Evommune, Inc.EVMNCommon Stock$3.15M184,0620.2%
SANOFI$3.08M63,4740.2%
Scholar Rock Holding Corp$3.07M69,5890.2%
NEKTAR THERAPEUTICS$3.05M72,0310.2%
ISHARES TR$2.97M12,0700.2%
Zura Bio Limited$2.95M562,0650.2%
OnKure Therapeutics, Inc.$2.94M1,014,1580.2%
UROGEN PHARMA LTD$2.94M125,3750.2%
LeonaBio, Inc.LONACommon Stock$2.89M393,7010.2%
BridgeBio Oncology Therapeutics, Inc.BBOTCommon Stock$2.83M226,2480.2%
Eledon Pharmaceuticals, Inc.$2.75M1,821,8120.2%
enGene Therapeutics Inc.$2.74M303,6860.2%
DYNAVAX TECHNOLOGIES CORP$2.61M170,0000.2%
Inovio Pharmaceuticals, Inc.$2.58M1,485,0080.2%
Viridian Therapeutics, Inc.$2.40M77,1980.2%
Pharvaris N.V.$2.37M85,5280.2%
Corbus Pharmaceuticals Holdings, Inc.CRBPCommon Stock$2.33M286,7810.2%
ASTRIA THERAPEUTICS INC$2.27M173,5570.2%
DELCATH SYSTEMS, INC.$2.27M224,3850.2%
Edgewise Therapeutics, Inc.$2.26M90,9990.2%
Grace Therapeutics, Inc.$2.22M641,9880.2%
REGENXBIO Inc.$2.09M144,8480.2%
Arcellx, Inc.$2.05M31,4840.2%
Olema Pharmaceuticals, Inc.$2.03M81,3990.2%
Masimo Corporation$1.95M15,0000.1%
Cybin Inc.$1.95M238,3900.1%
SOLENO THERAPEUTICS, INC.$1.94M41,8300.1%
Acumen Pharmaceuticals, Inc.$1.88M891,1830.1%
← PrevPage 2 of 5Next →